Literature DB >> 3163242

In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Y Glupczynski1, W Hansen, J Freney, E Yourassowsky.   

Abstract

The in vitro susceptibilities of 37 clinical isolates of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents were determined. Imipenem was the only drug with consistent activity (MIC for 90% of isolates, 2 micrograms/ml). Piperacillin, ticarcillin-clavulanic acid, ceftazidime, and co-trimoxazole were active against most strains. All the isolates were resistant to ampicillin, cefazolin, cefuroxime, cefamandole, cefotetan, ceftriaxone, cefotaxime, aztreonam, amdinocillin, and temocillin. Most isolates were resistant to the aminoglycosides tested, including amikacin. Lack of activity was also observed for all new 4-quinolone antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163242      PMCID: PMC172153          DOI: 10.1128/AAC.32.2.276

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Achromobacter septicemia-fatalities in prematures. I. Clinical and epidemiological study.

Authors:  J F FOLEY; C R GRAVELLE; W E ENGLEHARD; T D CHIN
Journal:  Am J Dis Child       Date:  1961-03

2.  Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.

Authors:  A L Barry; R N Jones; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Achromobacter xylosoxidans isolates in Hawaii.

Authors:  F D Pien; H Y Higa
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

4.  Neonatal meningitis caused by Achromobacter xylosoxidans.

Authors:  S S Namnyak; B Holmes; S E Fathalla
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

5.  Nosocomial colonization and infection by Achromobacter xylosoxidans.

Authors:  M E Reverdy; J Freney; J Fleurette; M Coulet; M Surgot; D Marmet; C Ploton
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

6.  Identification of Achromobacter species by cellular fatty acids and by production of keto acids.

Authors:  S B Dees; C W Moss
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

7.  Corneal ulcer due to Achromobacter xylosoxidans.

Authors:  P E Newman; P Hider; G O Waring; E O Hill; L A Wilson; T S Harbin
Journal:  Br J Ophthalmol       Date:  1984-07       Impact factor: 4.638

8.  Purification and properties of a beta-lactamase from Alcaligenes dentrificans subsp. xylosoxydans.

Authors:  T Fujii; K Sato; M Inoue; S Mitsuhashi
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

9.  Peritonitis caused by Alcaligenes denitrificans subsp. xylosoxydans: case report and review of the literature.

Authors:  A J Morrison; K Boyce
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

10.  A plasmid-mediated cephalosporinase from Achromobacter species.

Authors:  R Levesque; P H Roy; R Letarte; J C Pechère
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

View more
  29 in total

1.  Long-Term Follow-Up of Pediatric Patients After Congenital Coronary Artery Fistula Closure.

Authors:  Xiaoyong Li; Laichun Song; Ming Xu; Gangcheng Zhang; Jing Jin
Journal:  Pediatr Cardiol       Date:  2020-05-30       Impact factor: 1.655

2.  Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.

Authors:  H Peltroche-Llacshuanga; H Peltroche-Llacsahuanga; H Kentrup; G Haase
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

3.  First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.

Authors:  Julien Bador; Lucie Amoureux; Jean-Marie Duez; Anthony Drabowicz; Eliane Siebor; Catherine Llanes; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

4.  Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

Authors:  L Saiman; Y Chen; S Tabibi; P San Gabriel; J Zhou; Z Liu; L Lai; S Whittier
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

6.  Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans.

Authors:  D Decré; G Arlet; E Bergogne-Bérézin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism.

Authors:  M Cheron; E Abachin; E Guerot; M el-Bez; M Simonet
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Environmental Distribution and Drug Susceptibility of Achromobacter Xylosoxidans Isolated from Outdoor and Indoor Environments.

Authors:  Sachiko Nakamoto; Misaki Sakamoto; Kana Sugimura; Yuki Honmura; Yuki Yamamoto; Natsumi Goda; Hiroo Tamaki; Naoto Burioka
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

9.  Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.

Authors:  Yongfei Hu; Yuying Zhu; Yanan Ma; Fei Liu; Na Lu; Xi Yang; Chunguang Luan; Yong Yi; Baoli Zhu
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.